RU2015154806A - TSPO translocator protein ligands with antidepressant and nootropic activity - Google Patents

TSPO translocator protein ligands with antidepressant and nootropic activity Download PDF

Info

Publication number
RU2015154806A
RU2015154806A RU2015154806A RU2015154806A RU2015154806A RU 2015154806 A RU2015154806 A RU 2015154806A RU 2015154806 A RU2015154806 A RU 2015154806A RU 2015154806 A RU2015154806 A RU 2015154806A RU 2015154806 A RU2015154806 A RU 2015154806A
Authority
RU
Russia
Prior art keywords
antidepressant
protein ligands
translocator protein
nootropic activity
tspo
Prior art date
Application number
RU2015154806A
Other languages
Russian (ru)
Other versions
RU2015154806A3 (en
RU2699568C2 (en
Inventor
Сергей Борисович Середенин
Милада Альнордовна Яркова
Полина Юрьевна Поварнина
Григорий Владимирович Мокров
Татьяна Александровна Гудашева
Original Assignee
Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" filed Critical Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова"
Priority to RU2015154806A priority Critical patent/RU2699568C2/en
Publication of RU2015154806A publication Critical patent/RU2015154806A/en
Publication of RU2015154806A3 publication Critical patent/RU2015154806A3/ru
Application granted granted Critical
Publication of RU2699568C2 publication Critical patent/RU2699568C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (2)

1. Применение лиганда транслокаторного белка - N-бензил-N-метил-1-фенилпирроло[1,2-a]пиразин-3-карбоксамида - в качестве антидепрессантного и ноотропного средства.1. The use of a translocation protein ligand - N-benzyl-N-methyl-1-phenylpyrrolo [1,2- a ] pyrazine-3-carboxamide - as an antidepressant and nootropic agent. 2. Применение лиганда транслокаторного белка - N-бутил-N-метил-1-фенилпирроло[1,2-а]пиразин-3-карбоксамида - в качестве антидепрессантного средства.2. The use of a translocation protein ligand, N-butyl-N-methyl-1-phenylpyrrolo [1,2- a ] pyrazine-3-carboxamide, as an antidepressant agent.
RU2015154806A 2015-12-21 2015-12-21 Ligands of translocator protein tspo, having antidepressant and nootropic activity RU2699568C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2015154806A RU2699568C2 (en) 2015-12-21 2015-12-21 Ligands of translocator protein tspo, having antidepressant and nootropic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015154806A RU2699568C2 (en) 2015-12-21 2015-12-21 Ligands of translocator protein tspo, having antidepressant and nootropic activity

Publications (3)

Publication Number Publication Date
RU2015154806A true RU2015154806A (en) 2017-06-26
RU2015154806A3 RU2015154806A3 (en) 2019-07-17
RU2699568C2 RU2699568C2 (en) 2019-09-06

Family

ID=59240405

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015154806A RU2699568C2 (en) 2015-12-21 2015-12-21 Ligands of translocator protein tspo, having antidepressant and nootropic activity

Country Status (1)

Country Link
RU (1) RU2699568C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2757476C2 (en) * 2020-04-14 2021-10-18 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Leucyltryptophan tspo ligands with anxiolytic activity
CN114432455A (en) * 2022-03-25 2022-05-06 江苏省人民医院（南京医科大学第一附属医院） Preparation and application of medicine for treating chronic pain-depression co-disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735401B2 (en) * 1996-08-28 2001-07-05 Pfizer Inc. Substituted 6,5-hetero-bicyclic derivatives
RU2194707C2 (en) * 2000-04-04 2002-12-20 Научно-исследовательский институт фармакологии РАМН Pyrrolo[1,2-a]pyrazines or their fumarates showing antiarrhythmic and anti-ischemic activity
FR2919288B1 (en) * 2007-07-27 2009-09-04 Sanofi Aventis Sa 1,2,3,4-TETRAHYDROPYRROLO [1,2-A] PYRAZINE-6-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
EP2168963A1 (en) * 2008-09-25 2010-03-31 Linnea S.A. Process for the preparation of vinpocetine and apovincamine
WO2012168697A1 (en) * 2011-06-06 2012-12-13 Imperial Innovations Limited Methods to predict binding affinity of tspo imaging agents to tspo

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2757476C2 (en) * 2020-04-14 2021-10-18 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Leucyltryptophan tspo ligands with anxiolytic activity
CN114432455A (en) * 2022-03-25 2022-05-06 江苏省人民医院（南京医科大学第一附属医院） Preparation and application of medicine for treating chronic pain-depression co-disease

Also Published As

Publication number Publication date
RU2015154806A3 (en) 2019-07-17
RU2699568C2 (en) 2019-09-06

Similar Documents

Publication Publication Date Title
EA201891882A1 (en) NEW ANTIBODIES TO SIRPa AND OPTIONS OF THEIR THERAPEUTIC APPLICATION
FR3041691B1 (en) EXHAUST LINE WITH REAGENT INJECTOR
BR112018005745A2 (en) ziegler-natta-metallocene dual catalyst systems with activator supports.
MA44221A (en) SODIUM (2R, 5S, 13AR) -7,9-DIOXO-10 - ((2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1 ', 2': 4.5] PYRAZINO [2,1-B] OXAZEPIN-8-OLATE
EA201790432A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
DK3172209T3 (en) TABLET FORMULATION WITH 2-FLUORO-N-METHYL-4- [7- (QUINOLIN-6-YLMethyl) IMIDAZO [1,2-B] [1,2,4] TRIAZIN-2-YL] BENZAMIDE
RU2015154806A (en) TSPO translocator protein ligands with antidepressant and nootropic activity
MA51197A (en) PYRAZOLOPYRIMIDINES WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) ACTIVITY
EA201790526A1 (en) PHARMACEUTICAL COMBINATIONS OF CITAGLIPTINE
RU2015133919A (en) Modular Small Arms
RU2013122696A (en) SUBSTANCES HAVING ANGIOGENIC ACTIVITY
SG11202100961UA (en) CONDITIONALLY ACTIVE PROTEINS WITH pH SELECTIVITY
Parnes Klinicheskiy sluchay: appenditsit i serdtse
AU201613000S (en) A Salt Shaker
RU2013129711A (en) ANTIDIABETIC ACTIVITY SUBSTANCES
IT201700028966A1 (en) NEW MOLECULES WITH PESTICULTURAL ACTIVITY
TH171766B (en) pendant
Zhu You Asked We Answered
RU2013122165A (en) MATTER CONVERTER
RU2013145423A (en) 5-Oxypyrimidine Derivatives with Immunomodulating Activity
RU2015150006A (en) NEEDLE CASE
TH1601001559A (en) Complexes containing oligonucleotides with synergistic immune activity. and its use
RU2012147123A (en) AIRCRAFT
TH176426A (en) Oligonucleotide complexes with immunoglobulin activity. And its use
RU2014107068A (en) ROCKET